Terms: = Uterine cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169
91 results:
1. MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and ezh2.
Sinha A; Ghosh A; Ghosh A; Mathai S; Bhaumik J; Mukhopadhyay A; Maitra A; Biswas NK; Sengupta S
Clin Epigenetics; 2024 Mar; 16(1):40. PubMed ID: 38461243
[TBL] [Abstract] [Full Text] [Related]
2. Comparative analysis of ezh2, p16 and p53 expression in uterine carcinosarcomas.
Makk E; Bohonyi N; Oszter A; Éles K; Tornóczky T; Tóth A; Kálmán E; Kovács K
Pathol Oncol Res; 2023; 29():1611547. PubMed ID: 38146588
[No Abstract] [Full Text] [Related]
3. Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trials.
Richardson MT; Barry D; Steinberg JR; Thirunavu V; Strom DE; Holder K; Zhang N; Turner BE; Magnani CJ; Weeks BT; Young AMP; Lu CF; Wolgemuth TR; Laasiri N; Squires NA; Anderson JN; Karlan BY; Chan JK; Kapp DS; Roque DR; Salani R
Gynecol Oncol; 2024 Feb; 181():1-7. PubMed ID: 38096673
[TBL] [Abstract] [Full Text] [Related]
4. Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR-ezh2 interaction and enhances the efficacy of tazemetostat in endometrial cancer.
Chen L; Zheng X; Liu W; Sun Y; Zhao S; Tian L; Tian W; Xue F; Kang C; Wang Y
Cancer Lett; 2023 Dec; 578():216445. PubMed ID: 37866545
[TBL] [Abstract] [Full Text] [Related]
5. ezh2 activates Wnt/β-catenin signaling in human uterine fibroids, which is inhibited by the natural compound methyl jasmonate.
Ali M; Stone D; Laknaur A; Yang Q; Al-Hendy A
F S Sci; 2023 Aug; 4(3):239-256. PubMed ID: 37182601
[TBL] [Abstract] [Full Text] [Related]
6. Bioinformatic Analysis of miR-200b/429 and Hub Gene Network in Cervical cancer.
Shukla V; Mallya S; Adiga D; Sriharikrishnaa S; Chakrabarty S; Kabekkodu SP
Biochem Genet; 2023 Oct; 61(5):1898-1916. PubMed ID: 36879084
[TBL] [Abstract] [Full Text] [Related]
7. Mouse uterine stem cells are affected by endocrine disruption and initiate uteropathies.
Singh P; Bhartiya D
Reproduction; 2023 Mar; 165(3):249-268. PubMed ID: 36488194
[TBL] [Abstract] [Full Text] [Related]
8. Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners.
Dermawan JK; Dashti N; Chiang S; Turashvili G; Dickson BC; Ellenson LH; Kirchner M; Stenzinger A; Mechtersheimer G; Agaimy A; Antonescu CR
Genes Chromosomes Cancer; 2023 Mar; 62(3):152-160. PubMed ID: 36445224
[TBL] [Abstract] [Full Text] [Related]
9. Ultrasound microbubble-mediated delivery of ANLN silencing-repressed ezh2 expression alleviates cervical cancer progression.
Pan Y; Wei M; Gong T
Tissue Cell; 2022 Aug; 77():101843. PubMed ID: 35679682
[TBL] [Abstract] [Full Text] [Related]
10. USP7 inhibits TIMP2 by up-regulating the expression of ezh2 to activate the NF-κB/PD-L1 axis to promote the development of cervical cancer.
Li N; Geng F; Liang SM; Qin X
Cell Signal; 2022 Aug; 96():110351. PubMed ID: 35523402
[TBL] [Abstract] [Full Text] [Related]
11. DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting ezh2.
Chen R; Gan Q; Zhao S; Zhang D; Wang S; Yao L; Yuan M; Cheng J
BMC Cancer; 2022 May; 22(1):488. PubMed ID: 35505294
[TBL] [Abstract] [Full Text] [Related]
12. Sodium Valproate Modulates the Methylation Status of Lysine Residues 4, 9 and 27 in Histone H3 of HeLa Cells.
Rocha MA; de Campos Vidal B; Mello MLS
Curr Mol Pharmacol; 2023; 16(2):197-210. PubMed ID: 35297358
[TBL] [Abstract] [Full Text] [Related]
13. ezh2 and Endometrial cancer Development: Insights from a Mouse Model.
Fang X; Ni N; Wang X; Tian Y; Ivanov I; Rijnkels M; Bayless KJ; Lydon JP; Li Q
Cells; 2022 Mar; 11(5):. PubMed ID: 35269532
[TBL] [Abstract] [Full Text] [Related]
14. Non-coding RNAs-ezh2 regulatory mechanisms in cervical cancer: The current state of knowledge.
Zheng J; Chen L
Biomed Pharmacother; 2022 Feb; 146():112123. PubMed ID: 34915417
[TBL] [Abstract] [Full Text] [Related]
15.
Mardinian K; Adashek JJ; Botta GP; Kato S; Kurzrock R
Mol Cancer Ther; 2021 Dec; 20(12):2341-2351. PubMed ID: 34642211
[TBL] [Abstract] [Full Text] [Related]
16. Targeting ARID1A mutations in cancer.
Mullen J; Kato S; Sicklick JK; Kurzrock R
Cancer Treat Rev; 2021 Nov; 100():102287. PubMed ID: 34619527
[TBL] [Abstract] [Full Text] [Related]
17. TCF3 is epigenetically silenced by ezh2 and DNMT3B and functions as a tumor suppressor in endometrial cancer.
Gui T; Liu M; Yao B; Jiang H; Yang D; Li Q; Zeng X; Wang Y; Cao J; Deng Y; Li X; Xu P; Zhou L; Li D; Wang Z; Zen K; Huang DCS; Chen B; Wan G; Zhao Q
Cell Death Differ; 2021 Dec; 28(12):3316-3328. PubMed ID: 34175897
[TBL] [Abstract] [Full Text] [Related]
18. Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the ezh2/miR-181a pathway.
Dong P; Xiong Y; Konno Y; Ihira K; Kobayashi N; Yue J; Watari H
J Exp Clin Cancer Res; 2021 Jun; 40(1):216. PubMed ID: 34174908
[TBL] [Abstract] [Full Text] [Related]
19. Circ_0019435 Exerts Its Functions in the Cellular Process of Cervical cancer via Epigenetically Silencing DKK1 and PTEN.
Wang Q; Zhuo Z; Yu H; Wang C; Gao L
Reprod Sci; 2021 Oct; 28(10):2989-2999. PubMed ID: 34037956
[TBL] [Abstract] [Full Text] [Related]
20. HPV E7 affects the function of cervical cancer cells via the TAL1/lnc‑EBIC/KLHDC7B axis.
Wang J; Xiang F; Liu X; Ma X; Cai X; Yang Y; Shen X; Yuan C; Xiang Y; Xiao H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760214
[TBL] [Abstract] [Full Text] [Related]
[Next]
